Back to search

Article

Resistance mechanism to Notch inhibition and combination therapy in human T cell acute lymphoblastic leukemia

2022-12-23

Abstract excerpt

Gain-of-function mutations in NOTCH1 are among the most frequent genetic alterations in T cell acute lymphoblastic leukemia (T-ALL), making the Notch signaling pathway a promising therapeutic target for personalized medicine. Yet, a major limitation for long-term success of targeted therapy is relapse due to tumor heterogeneity or acquired resistance. Thus, we performed a genome-wide CRISPR-Cas9 screen to identif...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
da8b95a0-aedc-5679-aa9c-5c52744b7083
DOI
10.1101/2022.12.23.521745
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Resistance mechanism to Notch inhibition and combination therapy in human T cell acute lymphoblastic leukemiaDOI 10.1101/2022.12.23.521745
Select a neighboring publication to make it the new centre.